News & Events about Albireo Pharma Inc.
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations PR Newswire NEW YORK, Jan. 30, 2023 NEW YORK, Jan. 30, 2023 /PRNewswire/ -- If...
NEW YORK, Jan. 29, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CinCor Pharma, Inc. (NASDAQ: CINC)s sale to ...
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - LBC, ALBO, CINC, LMST STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - LBC, ALBO, CINC, LMST PR Newswire NEW YORK, Jan. 27, 2023 NEW YORK, Jan. 27, 2023 /PRNewswire...
NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased ...
Albireo Pharma, Inc. (NASDAQ:ALBO Get Rating) CEO Ronald Harold Wilfred Cooper sold 1,057 shares of the firms stock in a transaction dated Monday, January 23rd. The stock was sold at an average price of $43.80, for a total value of $46,296.60. Following the completion of the sale, the chief ...